Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study

Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study

ObjectiveIt is still unclear how glucocorticoids (GCs) affect the long-term clinical course of patients with SLE. The objective of this study is to explore the factors associated with GC-free treatment status.MethodsUsing data from the lupus registry of nationwide institutions, GC dose at registrati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lupus science & medicine 2022-09, Vol.9 (1), p.e000772
Hauptverfasser: Sada, Ken-ei, Katayama, Yu, Asano, Yosuke, Hayashi, Keigo, Miyawaki, Yoshia, Ohashi, Keiji, Katsuyama, Eri, Katsuyama, Takayuki, Takano-Narazaki, Mariko, Matsumoto, Yoshinori, Yoshimi, Ryusuke, Shimojima, Yasuhiro, Ohno, Shigeru, Kajiyama, Hiroshi, Ichinose, Kunihiro, Sato, Shuzo, Fujiwara, Michio, Yajima, Nobuyuki
Format: Artikel
Sprache:eng
Schlagworte:
Cross-sectional studies
epidemiology
Epidemiology and outcomes
glucocorticoids
Lupus
outcome assessment, health care
systemic lupus erythematosus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectiveIt is still unclear how glucocorticoids (GCs) affect the long-term clinical course of patients with SLE. The objective of this study is to explore the factors associated with GC-free treatment status.MethodsUsing data from the lupus registry of nationwide institutions, GC dose at registration was compared between short, middle and long disease durations of
ISSN:2053-8790
2053-8790
DOI:10.1136/lupus-2022-000772